The US Food and Drug Administration (FDA) has announced a Class 1 recall of all Impella left-sided blood pumps. “There is a potential risk that the Impella motor housing may come into contact with the distal stent of a transcatheter aortic valve replacement (TAVR),” the FDA’s announcement says. “The contact may damage or destroy the…